MKI67 and pituitary adenocarcinoma: More importantly, nuclear CDKN1B immuno­staining is significantly reduced in pituitary adenomas of all types, particularly in corticotropinomas, in association with high Ki-67 expression, and is lost in pituitary carcinomas (Lidhar et al. 1999, Korbonits et al. 2002).